Anders G. Holst - Publications

Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: November 28, 2025

NaV1.5 or KCa2 channel blockade does not increase arrhythmia risk in hypokalemic rabbit hearts, unlike KV11.1 inhibition with dofetilide.

Journal: International journal of cardiology. Heart & vasculature

Published: March 27, 2025

Quantification of cefuroxime and flucloxacillin in synovial tissue and bone using ultra-performance convergence chromatography-tandem mass spectrometry.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: January 11, 2024

Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial.

Journal: Nature medicine

Published: June 15, 2023

Association between primary care electrocardiogram markers and Alzheimer's disease.

Journal: Journal of the neurological sciences

Published: August 03, 2022

A phase 1 trial of AP30663, a KCa2 channel inhibitor in development for conversion of atrial fibrillation.

Journal: British journal of clinical pharmacology

Published: July 05, 2022

Associations between primary care electrocardiography and non-Alzheimer dementia.

Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Published: April 26, 2022

Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial.

Journal: Lancet (London, England)

Published: June 24, 2021

Fascicular heart blocks and risk of adverse cardiovascular outcomes: Results from a large primary care population.

Journal: Heart rhythm

Published: March 23, 2021

Electrocardiographic T-wave morphology and risk of mortality.

Journal: International journal of cardiology

Published: October 23, 2020

Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials.

Journal: Cardiovascular diabetology

Published: June 19, 2020

Comparison of the three-level and the five-level versions of the EQ-5D.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: May 26, 2020